Z-0528-2014 Class III Terminated

Recalled by Remel Inc — Lenexa, KS

FDA device recall Z-0528-2014 was initiated by Remel Inc on Nov 21, 2012 and is designated Class III. Reason for recall: Boxes labeled as CIP5 may contain cartridges of AMP5. The recall status is terminated (terminated Mar 12, 2014). Affected quantity: 60/5/50-disc cartridge boxes.

Recall details

Product Type
Devices
Report Date
Dec 25, 2013
Initiation Date
Nov 21, 2012
Termination Date
Mar 12, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
60/5/50-disc cartridge boxes

Product description

Oxoid Antimicrobial Susceptibility Test Discs, CTO425B Ciprofloxacin CIP 5 mcg, 50 discs per cartridge, 5 cartridges per box. The firm name on the box label is Oxoid Ltd., Basingstoke, UK. Used in the semi-quantitative agar diffusion test method for in vitro susceptibility testing to assist in the determination of a suitable antibiotic agent for treatment purposes.

Reason for recall

Boxes labeled as CIP5 may contain cartridges of AMP5.

Distribution pattern

Nationwide Distribution including AL, CA, CO, FL, IA, KS, LA, MA, MS, NE, NH, NJ, NY, OK, OR, RI, TN, TX, VA, WA WI, and Puerto Rico.

Code information

Lot number: 1220205, exp July 21, 2015

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0528-2014
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0528-2014. Report a data issue: hello@regdatalab.com.